Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jo Knight

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
Pharmacogenetics and Genomics|February 22, 2022
Accuracy and applications of sequencing and genotyping approaches for CYP2A6 and homologous genesAlec W R Langlois, Ahmed El-Boraie, Koya Fukunaga, et al.
Journal of Human Genetics|April 14, 2023
Genotyping, characterization, and imputation of known and novel CYP2A6 structural variants using SNP array dataAlec W R Langlois, Ahmed El-Boraie, Jennie G Pouget, et al.
Archives of General Psychiatry|January 4, 2006
A common haplotype of the dopamine transporter gene associated with attention-deficit/hyperactivity disorder and interacting with maternal use of alcohol during pregnancyKeeley-Joanne Brookes, Jon Mill, Camilla Guindalini, et al.
Addiction (Abingdon, England)|November 18, 2021
Does sex alter the relationship between CYP2B6 variation, hydroxybupropion concentration and bupropion-aided smoking cessation in African Americans? A moderated mediation analysisMeghan J Chenoweth, Annie R Peng, Andy Z X Zhu, et al.
Inflammatory Bowel Diseases|July 16, 2015
Predictors of Outcome in Ulcerative ColitisMatti Waterman, Jo Knight, Amreen Dinani, et al.
Journal of Human Genetics|January 12, 2008
Association of the serotonin transporter gene, neuroticism and smoking behavioursColin O'Gara, Jo Knight, John Stapleton, et al.
Human Molecular Genetics|February 3, 2009
Depression Case Control (DeCC) Study fails to support involvement of the muscarinic acetylcholine receptor M2 (CHRM2) gene in recurrent major depressive disorderSarah Cohen-Woods, Daria Gaysina, Nick Craddock, et al.
Clinical Pharmacology and Therapeutics|December 10, 2020
Transferability of Ancestry-Specific and Cross-Ancestry CYP2A6 Activity Genetic Risk Scores in African and European PopulationsAhmed El-Boraie, Meghan J Chenoweth, Jennie G Pouget, et al.
Plos One|January 26, 2018
Examining the role of common and rare mitochondrial variants in schizophreniaVanessa F Gonçalves, Stephanie N Giamberardino, James J Crowley, et al.
Neurology|October 3, 2019
<i>APOE</i> ε4, white matter hyperintensities, and cognition in Alzheimer and Lewy body dementiaSaira Saeed Mirza, Usman Saeed, Jo Knight, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Pharmacogenetics and Genomics|February 22, 2022
Accuracy and applications of sequencing and genotyping approaches for CYP2A6 and homologous genesAlec W R Langlois, Ahmed El-Boraie, Koya Fukunaga, et al.
Journal of Human Genetics|April 14, 2023
Genotyping, characterization, and imputation of known and novel CYP2A6 structural variants using SNP array dataAlec W R Langlois, Ahmed El-Boraie, Jennie G Pouget, et al.
Archives of General Psychiatry|January 4, 2006
A common haplotype of the dopamine transporter gene associated with attention-deficit/hyperactivity disorder and interacting with maternal use of alcohol during pregnancyKeeley-Joanne Brookes, Jon Mill, Camilla Guindalini, et al.
Addiction (Abingdon, England)|November 18, 2021
Does sex alter the relationship between CYP2B6 variation, hydroxybupropion concentration and bupropion-aided smoking cessation in African Americans? A moderated mediation analysisMeghan J Chenoweth, Annie R Peng, Andy Z X Zhu, et al.
Inflammatory Bowel Diseases|July 16, 2015
Predictors of Outcome in Ulcerative ColitisMatti Waterman, Jo Knight, Amreen Dinani, et al.
Journal of Human Genetics|January 12, 2008
Association of the serotonin transporter gene, neuroticism and smoking behavioursColin O'Gara, Jo Knight, John Stapleton, et al.
Human Molecular Genetics|February 3, 2009
Depression Case Control (DeCC) Study fails to support involvement of the muscarinic acetylcholine receptor M2 (CHRM2) gene in recurrent major depressive disorderSarah Cohen-Woods, Daria Gaysina, Nick Craddock, et al.
Clinical Pharmacology and Therapeutics|December 10, 2020
Transferability of Ancestry-Specific and Cross-Ancestry CYP2A6 Activity Genetic Risk Scores in African and European PopulationsAhmed El-Boraie, Meghan J Chenoweth, Jennie G Pouget, et al.
Plos One|January 26, 2018
Examining the role of common and rare mitochondrial variants in schizophreniaVanessa F Gonçalves, Stephanie N Giamberardino, James J Crowley, et al.
Neurology|October 3, 2019
<i>APOE</i> ε4, white matter hyperintensities, and cognition in Alzheimer and Lewy body dementiaSaira Saeed Mirza, Usman Saeed, Jo Knight, et al.
Pageof 10